JCR Pharmaceuticals Co.,Ltd. FY2027 Q1 Earnings Report

Quick View

Executive Summary

The key point of this quarter’s results is that, despite securing revenue growth, the operating loss expanded significantly from the previous year due to a sharp increase in SG&A expenses. Revenue was ¥97.0B (+13.2% YoY), Operating Income was ¥-21.0B (¥-6.1B in the previous year), Ordinary Income was ¥-20.8B (¥-7.5B in the previous year), and consolidated Net Income was ¥-19.2B (¥-5.7B in the previous year). While the earnings structure improved, with the gross margin improving to 76.8% (up +4.3pt from 72.5% in the previous year), SG&A expenses surged to ¥95.5B (¥68.2B in the previous year, +40.1%), exceeding gross profit of ¥74.5B. This was the direct cause of the wider loss.

Factors Affecting Financial Results

【Revenue】Revenue was ¥97.0B, representing a +13.2% increase YoY. As the Company operates in a single segment (Pharmaceuticals Business), no breakdown by business is disclosed. However, gross profit was ¥74.5B and the gross margin improved to 76.8% from 72.5% in the previous year, an improvement of +4.3pt. In addition to revenue growth, improvements in product mix and cost efficiency appear to have contributed.

【Profit and Loss】The primary cause of the deterioration in Operating Income to ¥-21.0B (¥-6.1B in the previous year) was the sharp increase in SG&A expenses to ¥95.5B (¥68.2B in the previous year, +40.1%), exceeding gross profit (¥74.5B). Non-operating income and expenses resulted in income of ¥2.6B, including foreign exchange gains of ¥0.6B. However, the increased burden of interest expense of ¥1.6B (nearly double the ¥0.8B in the previous year) resulted in Ordinary Income of ¥-20.8B (¥-7.5B in the previous year). Extraordinary income and expenses were zero in the current period (slightly negative in the previous year due to losses on disposal of fixed assets and other items), and Profit Before Tax was ¥-20.8B, approximately the same level as Ordinary Income. As corporate income taxes and other taxes of ¥-1.7B were recorded, reflecting a tax refund, consolidated Net Income was ¥-19.2B (¥-5.7B in the previous year), while Net Income attributable to owners of the parent was ¥-19.1B (¥-5.5B in the previous year). Despite revenue growth, this was a case of lower earnings due to higher fixed costs, with losses widening at the Operating Income, Ordinary Income, and Net Income levels.

Key Financial Indicators

【Profitability】The Operating Margin deteriorated by -14.6pt to -21.7% (-7.1% in the previous year), while the Net Profit Margin on a consolidated basis deteriorated by -13.1pt to -19.8% (-6.7% in the previous year). Although the gross margin improved by +4.3pt to 76.8% (72.5% in the previous year), the SG&A ratio rose sharply to 98.5% (79.6% in the previous year), becoming the primary cause of the deterioration in profitability. 【Cash Quality】Comprehensive Income was ¥-25.1B, representing a difference of ¥-6.0B from Net Income attributable to owners of the parent of ¥-19.1B. The primary cause was a ¥-6.1B deterioration in valuation differences on investment securities; in addition to business operating results, market factors further reduced Comprehensive Income. 【Investment Efficiency】ROE was -4.4% (-1.2% in the previous year). Against total assets of ¥1,064.0B, revenue was ¥97.0B, resulting in total asset turnover of only 0.091x, indicating a low level of asset efficiency. 【Financial Soundness】The Equity Ratio declined by -2.3pt to 40.6% (42.9% in the previous year). Interest-bearing debt (short-term borrowings of ¥420.9B + long-term borrowings of ¥118.5B) was ¥539.4B, approximately unchanged from the previous year, but stood at approximately 1.25x equity. The current ratio was 108.9% and the quick ratio was 104.4%, maintaining a minimum safety margin.

Cash Flow Analysis

As no figures are available based on the classification disclosed in the statement of cash flows, cash trends are analyzed based on changes in balance sheet balances. Cash and deposits were ¥96.6B, down ¥43.5B (-31.0%) from ¥140.1B in the previous year, indicating that cash on hand is declining while operating losses continue. Accounts receivable and notes receivable increased to ¥156.9B (¥141.6B in the previous year, +10.8%), with receivables growing slightly ahead of revenue. Accounts payable also increased to ¥6.7B (¥5.2B in the previous year, +28.3%). Construction in progress, included in property, plant and equipment, remained high at ¥192.6B, suggesting that capital expenditures continue to absorb funds. Borrowings totaled ¥539.4B, comprising short-term borrowings of ¥420.9B and long-term borrowings of ¥118.5B, remaining approximately unchanged from the previous year. This suggests that the decline in cash on hand is being partially offset through continued borrowing.

Quality of Earnings

Ordinary Income was ¥-20.8B, while extraordinary income and expenses were zero in the current period (slightly negative in the previous year due to losses on disposal of fixed assets and other items). Accordingly, there was virtually no difference between Profit Before Tax (¥-20.8B) and Ordinary Income. The deterioration in earnings was therefore not attributable to extraordinary factors, but was primarily driven by recurring factors associated with the expansion of the operating loss in the core business. Of the ¥2.6B in non-operating income, the ¥0.6B foreign exchange gain includes an element related to market fluctuations, whereas the ¥1.6B in interest expense is a recurring cost linked to the balance of interest-bearing debt. Both items should be considered separately from the profit and loss structure of the core business. Comprehensive Income was ¥-25.1B, representing a difference of ¥-6.0B from Net Income attributable to owners of the parent of ¥-19.1B. The primary cause was a ¥-6.1B deterioration in valuation differences on securities resulting from the fair-value measurement of investment securities, with market factors separate from business operating results further reducing Comprehensive Income.

Earnings Forecasts and Guidance

The full-year forecast is revenue of ¥457.0B (+13.3% YoY), Operating Income of ¥11.0B (+98.2%), and Ordinary Income of ¥5.0B (-57.1%). Q1 revenue of ¥97.0B represents progress of 21.2% against the full-year forecast. Meanwhile, Q1 Operating Income and Ordinary Income were losses of ¥-21.0B and ¥-20.8B, respectively, representing substantial delays in progress toward the plan to achieve full-year profitability. The Company has not revised its earnings forecast or dividend forecast and has maintained its plan based on an improvement in earnings in the second half of the fiscal year.

Shareholder Returns

The annual dividend forecast is ¥10.00 (unchanged from the previous fiscal year), with no revision to the dividend forecast as of the end of this quarter. Compared with the full-year forecast EPS of ¥1.64, the Payout Ratio is approximately 610%, meaning that the planned total dividend amount substantially exceeds Net Income. As an operating loss has occurred in Q1, the dividend may depend on an allocation from retained earnings of ¥281.0B (down ¥31.3B YoY, -10.0%). There is no disclosure regarding the acquisition of treasury shares.

Risk Factors

1. Risk of deteriorating profitability due to fixed costs preceding revenue growth: SG&A expenses were ¥95.5B (98.5% of revenue), exceeding gross profit of ¥74.5B, and the Operating Margin deteriorated to -21.7% (-7.1% in the previous year). If elevated fixed costs continue, the loss-making structure may become prolonged.

2. Liquidity and refinancing risk: Short-term borrowings account for ¥420.9B of interest-bearing debt of ¥539.4B, while cash and deposits were ¥96.6B, representing only 0.23x the amount of short-term borrowings. As Operating Income was negative, the interest coverage ratio (Operating Income/interest expense) was also -13.4x, indicating that interest payments cannot be covered by core business earnings.

3. Risk of delays in the commencement of operations of capital expenditures: Construction in progress was ¥192.6B, accounting for 49.4% of property, plant and equipment. Delays in the commencement of operations or uncertainty regarding investment recovery could affect future depreciation expenses and asset efficiency.

Industry Benchmark (For Reference; Compiled by the Company)

Profitability and Returns

In terms of profitability, both the Operating Margin and Net Profit Margin were significantly below the industry median, placing the Company in the lower tier of the industry.

Growth and Capital Efficiency

The Revenue Growth Rate exceeded the industry median, indicating a relatively high level within the industry in terms of top-line growth.

※Source: Compiled by the Company

Key Points from the Financial Results

1. Despite revenue growth and an improvement in the gross margin (+4.3pt), SG&A expenses increased +40.1% YoY and exceeded gross profit. This was the direct cause of the deterioration in operating results, with the change in the cost structure being the most significant feature of the current period’s results.

2. Against the full-year earnings forecast of Operating Income of ¥11.0B, Q1 recorded a loss of ¥-21.0B, indicating a plan with a high degree of dependence on the second half of the fiscal year in terms of progress. No revision to the earnings forecast has been made.

3. The dividend forecast of ¥10.00 remains unchanged, but the planned Payout Ratio against full-year forecast EPS of ¥1.64 is approximately 610%. The fact that this represents a level premised on an allocation from retained earnings is a notable point that can be identified from the financial results data.

Theoretical Share Price (Reference Value)

This is a reference range mechanically calculated solely from publicly disclosed data using a residual income model (Ohlson-type model with an explicit 5-year fade). It is not a forecast of the market share price or a recommendation of any specific investment action.

Sensitivity: ¥265–¥280 at Cost of Equity ±1%; ¥270–¥274 at ω±0.1.

Notes:

• Net Income is significantly compressed relative to Operating Income due to tax burdens, acquisition-related expenses, minority interests, and other factors (Net Income ÷ Operating Income 18%). This figure reflects that compression at face value; if the factors are temporary, the underlying earnings power may be higher.
• As forecast ROE is below the Cost of Equity, the theoretical value is below Book Value Per Share.
• Net assets as of the quarter-end are used (there is a timing difference from the full-year forecast).
• As net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.

(Calculation model: Residual Income Model / Interest benchmark month: 2026-06 / This figure is not a forecast or guarantee of the future share price.)

---

This report is an earnings analysis document automatically generated by AI through analysis of XBRL earnings summary data. It does not recommend investment in any specific security. Industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting with a professional as necessary.

---End of Report---